References
- Cyanokit, Important Safety Information and Indication. Meridian Medical Technologies; [Internet]; 2015. Available from: http://www.cyanokit.com/treatment-with-cyanokit
- Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med. 1999;34:646–656.
- Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Baltimore). 2004;83:265–273.
- Haymond S, Cariappa R, Eby CS, et al. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005;51:434–444.
- Ohlgisser M, Adler M, Ben-Dov D, et al. Methaemoglobinaemia induced by mafenide acetate in children. A report of two cases. Br J Anaesth. 1978;50:299–301.
- Lee J, Mukai D, Kreuter K, et al. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med. 2007;49:802–805.
- Livshits Z, Lugassy DM, Shawn LK, et al. Falsely low carboxyhemoglobin level after hydroxocobalamin therapy. N Engl J Med. 2012;367:1270–1271.
- Pamidi PV, DeAbreu M, Kim D, et al. Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements. Clin Chim Acta. 2009;401:63–67.
- Baud F. Clarifications regarding interference of hydroxocobalamin with carboxyhemoglobin measurements in victims of smoke inhalation. Ann Emerg Med. 2007;50:625–626.
- Borron SW, Uhl W, Nolting A, et al. Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning. Ann Emerg Med. 2007;50:624–625.